SOLA Pharmaceuticals, LLC drugs

7 results
SOLA Pharmaceuticals, LLC
Usage: Diclofenac potassium tablets are indicated for treating primary dysmenorrhea, relieving mild to moderate pain, and alleviating symptoms associated with osteoarthritis and rheumatoid arthritis. Use the lowest effective dose for the shortest duration, considering potential risks.
SOLA Pharmaceuticals, LLC
Usage: Diclofenac potassium tablets are indicated for the treatment of primary dysmenorrhea, relief of mild to moderate pain, and alleviation of symptoms associated with osteoarthritis and rheumatoid arthritis. Use the lowest effective dose for the shortest duration necessary to meet individual treatment goals.
SOLA Pharmaceuticals, LLC
Usage: Ibuprofen tablets are indicated for relief of signs and symptoms of rheumatoid arthritis and osteoarthritis, mild to moderate pain, and primary dysmenorrhea. Use the lowest effective dose for the shortest duration based on individual treatment goals. Safety in children has not been established.
SOLA Pharmaceuticals, LLC
Usage: Ketorolac tromethamine ophthalmic solution is indicated for temporary relief of ocular itching due to seasonal allergic conjunctivitis and for treating postoperative inflammation following cataract extraction.
SOLA Pharmaceuticals, LLC
Usage: Ketorolac tromethamine is indicated for the short-term management of moderately severe acute pain in adults, typically post-surgery, for a maximum of 5 days. Initial treatment should be given via intravenous or intramuscular routes, with oral administration as a continuation if needed.
SOLA Pharmaceuticals, LLC
Usage: Ropivacaine Hydrochloride is indicated for local or regional anesthesia in surgery, including epidural blocks for cesarean sections and major nerve blocks, as well as for acute pain management through continuous infusion or local infiltration during postoperative care or labor.
SOLA Pharmaceuticals, LLC
Usage: Teriflunomide is indicated for the treatment of relapsing forms of multiple sclerosis (MS) in adults, which includes clinically isolated syndrome, relapsing-remitting MS, and active secondary progressive MS.